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A low-molecular weight eosinophil chemotactic factor 
(ECF-G), isolated and partially purified from livers of 
mice with schistosomiasis, was injected intradermally 
into guinea pigs. Biopsies obtained were studied for 
inflammatory cell accumulation in the injected sites and 
compared with those in the control sites injected with 
phosphate buffered saline. Tissue eosinophilia was seen 
as early as 1 hr after injection of ECF-G, but not in the 
control site. The increase of eosinophilia appeared bi-
phasic with peaks at 6 and 24 hr. Mast cells increased in 
both ECF-G and saline injected sites and the increase 
was still found at 120 hr after injection. Neutrophils also 
increased in both ECF -G and saline injected sites but 
disappeared within 48 hr . . 
These findings indicate that ECF-G is a tissue and 
species nonspecific eosinophil chemotactic factor, and 
. injection of EC'F-G initiates interaction of eosinophils 
and mast cells in the skin. 
Tissue eosinophilia has been found in a variety of skin dis-
eases such as pemphigus [1], bullous pemphigoid [2,3], derma-
titis h erpetiformis [3,4] , herpes gestationis [5] and toxic ery-
thema of t h e newborn [6]. Although the functional role of 
eosinophils in these lesions is not completely understood, de-
tection of chemotactic factors in tissue fluids [7,8], serum [9,10] 
and cell culture medium [11] has been facilitated by application 
of the micropore filter technique developed by Boyden [12]. 
Mice infected with Schistosoma mansoni (S. mansoni) man-
ifest eosinophilia in peripheral blood [13] as well as in hepatic 
granulomas [14,15]. Recently we extracted and partially puri-
fied an eosinophil ch emotactic factor (ECF -G) from these livers 
[16]. ECF-G is a low molecular weight acidic peptide that is 
ch emotactic for eosinophils in vitro . In this study we investi-
gated histopathological changes induced in guinea pig skin by 
injection of ECF-G. Types of cells responding in vivo and the 
duration of events were characterized. 
MATERIALS AND METHODS 
An.imals 
Nine male albino guinea pigs of the Hartley strain weighing approx-
imately 350 gm obtained from Simonsen Laboratories (Gilroy, Calif.) 
were maintained under standard laboratory conditions. 
Preparation of ECF -G: The method has been described in detail 
[16]. Essentially, livers of mice after 8 weeks of infection with 50 
cercariae of S. mansoni were homogenized in saline and dialyzed 
against water (100 x v/ v) using Spectra/por 3 membrane (Spectrum 
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Medical Industries, Inc., Los Angeles, Calif.). The diffusate was lyoph-
ilized, reconstituted by cold distilled water and applied to a Sephadex 
G-25 fine (Pharmacia Fine Chemicals, P iscataway, N.H.) column (1.6 
X 92.6 cm) pre-equilibrated with 0.067 M pi:osphate buffered saline 
(PBS), pH 7.4. The fractions obtained were tested for t,",eir chemotactic 
activity for eosinophils in vitro using Blind-well chemotactic chambers 
and polycarbonate membrane filters with 5.0 /-Lm pores (Nucleopore 
Corp., P leasanton, Calif.) . Horse serum induced guinea pig peritoneal 
eosinophils were used as indicator cells. The majority of eosinophil 
chemotactic activity was detected in 5 tubes (2.5 ml each) just after 
elu tion of the molecular marker, Vitamin B12 (m.w. 1355.4). These 
fractions were pooled and lyophilized. 
Injections of ECF-G 
The hair over the dorsal aspect of 9 animals was removed by 
application of wax hair remover 1 day before injection. Eight sites, 1 
cm2 and at least 2 em apart, were marked in ink. Lyophilized ECF-G 
was dissolved in 5 ml of water passed through a Milipore filter, and 0.1 
ml (approximately 1.2 /-Lg ECF-G) was injected intradermaLly in to 6 
sites. The other 2 sites were injected with 0.1 ml of PBS. The skin sites 
were excised at I, 6, 12, 24, 48 and 120 hr, from 2-3 animals at each 
period. Although a total of 54 sites were injected with ECF-G only 36 
sites, where clear cut bleb was noted, were selected for biopsy. Similarly, 
12 out of 18 sites injected with PBS were used for examination. 
Histological Study 
The specimens were fixed in Bouin-HoLiande fluid (2.5 gm copper 
acetate, 4 gm picric acid, 10 ml formaldehyde and 1.5 ml glacial acetic 
acid in 100 ml distilled water) for 18 hr, dehydrated in alcohol, em-
bedded in paraffin and sectioned at 4 /-L. Eosinophils were stained 
according to Litt's modification of the Dominici stain [17] and t issue 
mast cells stained with 0.1% aqueous toluidine blue O. A total of 10 
randomly selected high power fields (hpf) (10 X 40) were counted in 
the upper dermis for each specimen. 
RESULTS 
1. Macroscopic Observations 
The swelling due to injection of ECF -G disappeared in 30 
min, but in all instances mild edema a nd erythema began to 
appear during the first hr and reached a maximum about 6 to 
24 hr after injection. The reaction subsided within 48 lu·. 
2. Light Microscopic Study 
As early as llu' after injection, eosinophils were found around 
the dilated capillary vessels in the upper dermis (Figure). They 
showed orange-colored granules and were considered to be 
mature eosinophils. Endothelial cells of the vessels appeared to 
be swollen. Other inflammatory cells found in the area included 
mas t cells and neutrophils. Some specimens, especially at 24 lu' 
after ECF -G injection, formed necrotic foci in the deep dermis. 
The cell types found in these abscesses could not be clarified 
due to cell destruction. The number of inflammatory cells 
counted are summarized in the Table and compared to the 
control sites injected with PBS alone. Tissue eosinophilia was 
characterized by a biphasic response with peaks at 6 and 24 lu'; 
a mild eosinophilia was still seen by 48 lu', but very few 
eosinophils were found by 120 hr. Accumulation of eosinophils 
was not seen by injection of PBS. Mast cells increased in both 
ECF-G and PBS injected sites, and 120 hr after injection the 
216 
April 1980 
number was slightly more than before injection. Neutrophils 
also increased in both ECF-G and PBS injected sites, but they 
disappeared within 48 hr. 
DISCUSSION 
ECF -G showed chemotactic activity in guinea pig skin in 
vivo by intradermal injection. Accumulation of eosinophils, but 
not neutrophils, was observed as early as 1 hr after injection, 
indicating that ECF -G is tissue nonspecific. In a previous report 
[16], we described the apparent identity of a portion of ECF-G 
with the synthetic tetrapeptide Ala-Gly-Ser-Glu characterized 
by Goetzl and Austen [18] as a component of the mediator of 
type 1 hypersensitivity ECF-A [19,20]. ECF-G also shares com-
mon features with eosinophil chemotactic factor isolated from 
pemphigoid blister fluid [7,8] and ECF isolated from a patient 
with an anaplastic large cell carcinoma of the lung [21] and the 
low molecular weight ECF from tissue culture of lymph node 
Cutaneous response to the injection of ECF-G. A marked eosinophil 
accumulation is seen around the dilated capillary vessels at the upper 
dermis. Arrows indicate eosinophils (x 750). 
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cells of a patient with Hodgkin's disease ell]. However, it also 
contains a portion whose molecular weight seems to be larger. 
The response of tissue eosinophils to ECF -G was biphasic 
with peaks at 6 and 24 hr. This dual response is comparable to 
the observation of Turnbull, Evans, and Kay [22] in which 
synthetic acidic tetrapeptides Val-Gly-Ser-Glu and Ala-Gly-
Ser-Glu were applied by skin windows in humans. Muller and 
Healy [23] and Hirashima and Hayashi [24] reported that tissue 
eosinophilia in experimentally produced cutaneous anaphylaxis 
was also biphasic. The biphasic course may be a natural tissue 
eosinophil response to an exogenous stimulus, although the 
specific reason remains unknown. Another possibility is that 
the second phase of eosinophilia may result from induction of 
eosinophilopoietin. Mahmoud, Stone, and Kellermeyer [25] 
reported that injection of anti-eosinophil serum into mice de-
pleted mature eosinophils and induced eosinophilopoietin 
which stimulates eosinophiopoiesis in vivo. The sudden transfer 
of eosinophils from the circulation into skin in the fIrst phase 
may become a stimulus, inducing an eosinophilopoietin-like 
substance in the guinea pig. However, it is also conceivable that 
we injected the stimulating factor with ECF-G, since the injec-
tion material was collected from Sephadex G-25 column chro-
matography and the molecular weight of both eosinophilopoie-
tin and ECF-G is essentially the same by gel flltration. 
Participation of mast cells in various forms of inflammation 
in skin has been considered to be pertinent [26]. Activation of 
mast cells has been shown to release histamine [27-30] as well 
as ECF-A [9] into the circulation. Thus we examined skin 
biopsies with toluidine blue staining to determine if mast cells 
and eosinophils accumulated together. There was a tendency 
for a biphasic elevation in the number of mast cells. Fluctuation 
of mast cell counts paralleled that of eosinophils in the upper 
dermis but the results were inconclusive due to our inability to 
adequately quantitate mast cells since plastic embedding was 
not done [26,31]' The fmdings nevertheless contrast with those 
of Hirashima and Hayashi [24] who injected dinitrophenyl 
ascari extract into guinea pig. They found that mast cells were 
reduced during the fIrst 6 hr after injection while eosinophils 
increased. In the present study, the number of mast cells 
returned to the normal base line by 12 hr after injection, but 
increased again following a rise of eosinophil counts. The lack 
of correlation in this study due to technique, however, does not 
detract from the general view that mast cells and eosinophils 
interact meaningfully in inflammation. Archer and McGovern 
[32] reported that mast cells accumulated in sites of developing 
eosinophilia after infection with the parasite Amplicaecum 
robertsi. Both eosinophils and mast cells declined in number 
by 48 hr after injection and eosinophilia was not found by 120 
hr although a considerable number of mast cells was found in 
the skin sites. However, in the liver of mice with schistosomiasis 
eosinophils and mast cells remained in granulomas as long a~ 
16 to 20 weeks [33]. Chronic inflammation may be manifested 
by continuous ECF -G synthesis and prolonged interaction of 
eosinophils and mast cells in the granulomas. 
Inflammatory cell responses" induced in guinea pig skin by intradermal injection of ECF-G and PBS 
Number of Eosinophil Mast CeU Hours after specinlens Neutrophil 
injection 
ECF-G PBS ECF-G PBS ECF-G PBS ECF-G PBS 
0 5 11 ± 6 29 ± 6 0 
1 3 2 43 ± 15 8±5 41 ± 9 96 ± 58 42 ± 16 41 ± 36 
6 5 3 73 ± 21 12 ± 6 68 ± 22 45 ± 17 9±3 7±5 
12 3 ND" 43 ± 4 ND 26 ± 8 ND 37 ± 15 ND 
24 6 3 77±11 16 ± 9 42 ± 13 64 ± 45 26 ± 13 10 ± 9 
48 5 2 30 ± 10 6±2 70 ± 23 15 ± 10 3 ± 1 0 
120 2 2 7±3 1 ± 1 54 ± 29 52 + 26 0 0 
" Number of cells per 10 representative fields at x400. 
" ND: Not done. 
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